Tag: NYSE:ABBV

Technologies

Abbvie Inc (NYSE: ABBV) Has Gained 3.03% YTD: Is There Trouble Ahead?

During the last session, Abbvie Inc (NYSE:ABBV)’s traded shares were 4.78 million, with the beta value of the company hitting 0.49. At the end of

Business

Abbvie Inc (NYSE:ABBV) Is Up 6.29% Over The Past 30 Days: Is There Trouble Ahead?

In recent trading session, Abbvie Inc (NYSE:ABBV) saw 1.32 million shares changing hands at last check today with its beta currently measuring 0.48. Company’s recent

Technologies

Abbvie Inc (NYSE: ABBV) At Current Prices: Is It Worth Investing In?

During the recent session, Abbvie Inc (NYSE:ABBV)’s traded shares were 1.39 million, with the beta value of the company hitting 0.53. At the last check

Business

With 16.04% Distance From Low, Is Abbvie Inc (NYSE:ABBV) Poised For More Gains?

In recent trading session, Abbvie Inc (NYSE:ABBV) saw 2.78 million shares changing hands at last check today with its beta currently measuring 0.58. Company’s recent

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: NYSE:ABBV

Abbvie Inc (NYSE: ABBV) Has Gained 3.03% YTD: Is There Trouble Ahead?

Abbvie Inc (NYSE:ABBV) Is Up 6.29% Over The Past 30 Days: Is There Trouble Ahead?

Abbvie Inc (NYSE: ABBV) At Current Prices: Is It Worth Investing In?

With 16.04% Distance From Low, Is Abbvie Inc (NYSE:ABBV) Poised For More Gains?

Quick Links

Categories